chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left arm stiffening; Caller states she had left arm pain with her first Covid vaccine, but not as bad as now; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Dec2021 (Lot number: unknown) at the age of 36 years as dose 2, single for covid-19 immunisation. Relevant medical history reported as No. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Anatomical Location : Left arm, Lot: unknown), administration date: 29Oct2021, when the patient was 36 years old, for COVID-19 immunization. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 16Dec2021, outcome "not recovered", described as "Left arm stiffening"; PAIN IN EXTREMITY (non-serious) with onset Dec2021, outcome "unknown", described as "Caller states she had left arm pain with her first Covid vaccine, but not as bad as now".  Additional information: Patient did not receive any additional vaccines on same date of the Pfizer Suspect. Patient did not receive any other vaccine prior covid 19 vaccine within four weeks. Family history not provided. She stated that her arm was stiffening up, she could not hold her phone. It was the arm in which she got the vaccine. She could not hold her arm up for more than a minute, and it has a feeling like blood was rushing to her hand. She stated that it started last night and happened after her second vaccine. She stated that the feeling goes away and comes back. She had left arm pain with her first Covid vaccine, but not as bad as now. She asked is this normal and she asked who should she contact and what should she be doing about this effect? Patient did not visited emergency room or physician office. No relevant test were reported.   Follow-up activities closed. Batch/lot number not available for [Vaccine/BNT162B2],; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101823808 Same patient and drug, different event separated in time
Patient experienced seizure episodes 5 hours after receiving DTaP, IPV, Hib, and PCV vaccines.   Patient was given Fosphenytoin 60mg IM X 1. The ER record received on 3/30/04 states hypothermia.
9 days after incurred lethargy, and appetite, unstable gait. ?? got progressively worse. 1 mo later was unable to sit or walk. Fed with acute cerbillar atoxia.
I have had a chronic ear infection that no antibiotics have cleared up since March 2021. I had a staph infection on my skin for three months and it took two rounds of antibiotic?s to clear it up.
Initial reaction was widespread redness and swelling at injection site.  Reaction continued with several pox breaking out on inner thighs, later on forearms and finally on torso.  Also had sores develop in mouth and tongue, and consistent headache for over a week.
Headache; sensitive to light and sound; queasy stomach; extreme fatigue - lasted from April 2, 2021 until April 4, 2021 11:00 AM
Headache, Diarrhea, malaise since 2/3/21 Narrative: Per nursing report: "2nd dose of Moderna vaccine Tuesday, February 2nd. States came to work yesterday [2/3] states feeling [g]roggy and warm but no fever. Today reports diarrhea and headache. States not feeling well."
Inappropriate schedule of vaccine administered; After second dose experiencing phantosmia.  Smelling very bad odors that don't exist; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8737) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication included eszopiclone (LUNESTA) from an unknown date for an unknown indication and unknown if its ongoing. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the right arm on 20Feb2021 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, after second dose, the patient experienced phantosmia. Smelling very bad odors that don't exist. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event phantosmia was not recovered/not resolved/ongoing.   No follow-up attempts are possible. No further information is expected.
muscle pain; This case was reported by a consumer and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had Muscle pain. For tolerances of 2nd dose refer case US2019AMR185877, reported by same reporter.
This spontaneous report as received from a registered nurse (R.N.) refers to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates, the patients were vaccinated with improperly stored GARDASIL (lot# K007828, expiration date 02-MAR-2017; lot# K010574, expiration date 08-APR-2017; dose and route were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Diagnosed with Shingles on October 19th. Symptoms started on October 17th
4-6 hours post vaccine,  mild fever, pain at injection site left arm, itchiness and bumps all over. Ibuprofen and Benadryl 50mg taken. Symptoms resolved. 5 days later, tinnitus in right ear occurs and has been ongoing since then.
Patient's mother called 8/9/2021 to report pt received Pfizer Covid 19 vaccine 2nd dose on 08/2/2021 at 11am and within 1 hour pt complained of bilateral leg muscle pain with changed in his gait "walks sideways". Used Motrin over the counter which helped but pain came back. Currently pain is progressing and worse.
Patient tested positive for Covid-19 on 01/19/2022.  Patient was asymptomatic and afebrile, and was moved to isolation at facility.  On 01/31/2022 patient noted to have a large amount of rectal bleeding in toilet, with abdominal pain and was transferred to ED for evaluation.  Patient returned the following day with orders to set up a GI consult.  Patient was noted to have unsteady gait, and felt dizzy.  Patient was then transferred to Hospital.  Patient expired on 03/07/2022.
Fever 102 next day, RED RASH NECK, TRUNK, FACE tired sleeping a lot decrease appetite
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning a six-year-old female. Neither medical history nor concomitant medication was reported for this patient. The product expired on 06-Dec-2010. On 20-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information received on 04-Mar-2011 and incorporated into case: no late occurring adverse events.
PATIENT HAD CHILLS AND STUFF; PATIENT HAD CHILLS AND STUFF; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY TRACT CONGESTION (PATIENT HAD CHILLS AND STUFF) and CHILLS (PATIENT HAD CHILLS AND STUFF) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (RINVOQ) (Oral) at an unspecified dose. In March 2021, the patient experienced RESPIRATORY TRACT CONGESTION (PATIENT HAD CHILLS AND STUFF) and CHILLS (PATIENT HAD CHILLS AND STUFF). In 2021, RESPIRATORY TRACT CONGESTION (PATIENT HAD CHILLS AND STUFF) and CHILLS (PATIENT HAD CHILLS AND STUFF) had resolved.            No concomitant medication was reported.   Treatment information was not provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Severe fatigue, aches, chills, very poor mental clarity.    I could not function at all.   Went to bed and slept 13 hours.
Patient fainted upon receiving Td and IPV vaccines. Looked pale, felt clammy and appeared anxious. Helped patient lay down, checked vital signs - BP 123/85, pulse 108. Offered patient a glass of water once the patient felt better. Patient left the clinic after 15 minutes of observation, denied any signs and symptoms of syncope at the time of departure. Encouraged parent and patient to follow up with their pediatrician.
After shot #2 I became physically ill for 7 days - headache, severe body aches, chills, extreme fatigue.  Two weeks after receiving shot #2 I developed severe eczema that became worse over the weeks until it covered both hands and wrists, this eczema (which I never had before) lasted ten months, confirmed by two dermatologists.  Twenty months later, I developed a sudden vascular retinal occlusion of my left eye.  I do not have hypertension, diabetes, high cholesterol, never smoked, and had a complete coagulopathy workup ordered, all was normal.  I am now receiving intravitreal injections, for the rest of my life.
This spontaneous report as received from a healthcare worker and a nurse refers to unspecified number of patients. Medical history and concomitant medications were unknown. It was reported that, improperly stored doses of PNEUMOVAX 23 (single dose vials, route of administrations, doses, lot numbers and expiry dates were not reported) were given to unspecified patients on unspecified dates. No adverse experience was reported. No product quality complaint (PQC) was involved. Follow up has been received from a healthcare worker on 06-JUL-2015: It was reported that on 26-MAR-2014, the patient of unknown age and gender was vaccinated with improperly stored PNEUMOVAX 23 (Lot number: J014404, Expiry date: 22-JAN-2015). This is one of several reports from the same reporter. Additional information has been requested.
My left arm was sore as expected. But I developed a rash near the injection site which traveled down and to the inner part of my arm (rash was about hand width).  The entire area was hot and tender to the touch.  It is better today (Monday, 11/14/2022).  I did not have a fever.
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. The registered nurse reported that on an unspecified dates an unknown number of patients had been administered GARDASIL (route, dose, frequency and lot # not reported) which had been improperly stored. No adverse effects reported. Additional information has been requested.
Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:
Flu symptoms, achiness, nausea, headache for about 24 hours. Went away with the rest and Tylenol
On Day 1 of second dose 4/21 - Felt weakness and light-headed  with slight muscle pain near the site On Day 2 - 4/22 - Severe muscle pain full-body, head ache and low energy On Day 3 0 4/23 - Reduced muscle pain through out body, Head ache consistent, and now developed swollen lymph node on right side with pain felt in right ear and throat when swallowing
Erythema on the injection site; Warm to touch; Arm soreness; Fatigue; A spontaneous report was received from a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced arm soreness, fatigue, erythema on the injection site, and warm to touch.   The patient's medical history was not provided. No relevant concomitant medications were provided.   On 24 Dec 2020, the patient received his first of two planned doses of mRNA-1273 (Lot: 011J20A) intramuscularly in left arm for prophylaxis of COVID-19.  On 26 Dec 2020, the patient experienced arm soreness and fatigue.  On 01 Jan 2021, the patient stated that she started having erythema on the injection site. She was not sure if it is a bug bite, but it is bigger than insect bites and warm to touch. No treatment information was provided.     Action taken with mRNA-1273 in response to the event was not reported.   The outcome for the events, headache, arm soreness, fatigue, erythema on the injection site, and warm to touch, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Within half hour of receiving vaccine I developed rash as well as my arm swelling. I took some BENADRYL - swelling went down & arm was normal by next day.
On 5/19/15 patient presented to clinic/office, for evaluation of concerns regarding left deltoid erythema and itching with onset of symptoms presenting seven days post-administration of PREVNAR 14 vaccine. No immediate concerns post-administration were noted. Patient manifested no symptoms of respiratory distress, or systemic reactive response. Advised to apply cool compress and may use OTC allergy-relief medications such as CLARITIN.
Site: Pain at Injection Site-Severe, Systemic: Body Aches Generalized-Severe, Systemic: ongoing pain in both shoulders-Severe, Systemic: Joint Pain-Severe, Additional Details: ongoing pain in both shoulders. diagnosed as "inflammatory pain" treated with success with daily steroids, failed nsaids
feeling like she had no strength in her upper body as if she were about to collapse; muscle weakness; have felt a little weak; muscles were being lost in the top of her, it stopped before got to legs; left side of neck sore; arm sore; arm soreness and  neck stiffness; This is a spontaneous report from a contactable consumer (Patient). A 87-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 06Feb2021 as single dose for covid-19 immunisation. Medical history included Left Hip Replacement from 17Dec2019 to an unknown date (she did experience a loss of feeling in her legs, and one time she even had a fall from it, like her legs did not hold her up). The patient's concomitant medications were not reported. The patient previously took enoxaparin sodium started the product on 20Dec2019 and stopped it on 27Dec2019, even though she was supposed to take it for 14 days. Patient got the first shot of vaccine on 06Feb2021 and her only side effects were that her arm was sore which present till 09Feb 2021, and her left side of her neck was sore from 07Feb2021 to 09Feb 2021. On 09Feb2021, she was at her kitchen sink and it was like her muscles were being lost, in the top of her, but it stopped before it got to her legs, and then she felt okay. she had not experienced that again, but on 10Feb2021, she has felt a little week. Caller is wondering if that could have been a side effect of the vaccine. Patient stated that, she was taller but she thinks she is now between 4' 11 and 5 foot. She got the vaccine in her left arm, and it was her left arm that was sore. she had no other vaccines on the same day as the COVID vaccine. Patient stated that after her hip replacement, she did experience a loss of feeling in her legs, and one time she even had a fall from it, like her legs did not hold her up. Patient stated that the fall occurred four days after starting a blood thinning medicine called Enoxaparin and once she stopped that medicine, she got to feeling better. she read somewhere that the COVID shot was given in the muscle, and that was why she thought the COVID shot might be related to her feeling like she was losing her muscles in her top half last night. The outcome of the event arm soreness, neck stiffness, left side of neck sore and muscles were being lost in the top of her, it stopped before got to legs was recovered and for other it was unknown.      Information on the lot/batch number has been requested.
SORE ARM AT INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802068, expiry: not reported) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced sore arm at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sore arm at injection site. This report was non-serious.
This spontaneous report was received from a physician, via company representative, referring to a male patient, age reported as "in his 20's". The patient's medical history, concomitant medications and concurrent conditions were not reported. On an unknown date, the patient received two doses of M-M-R II for prophylaxis (strength, frequency, therapy type, lot # and expiration date were not provided). On an unspecified date, reported as "in the 1990's", the patient had an unspecified blood titre test performed which showed a low titre result (rubella antibody negative, measles antibody negative and mumps antibody test negative). It was unknown by the reporter if any treatment was given due to the adverse events, or if the patient sought any medical attention. The outcome of rubella antibody negative, measles antibody negative and mumps antibody test negative was unknown.
Began to have numbness/tingling that extended to elbow ("like I hit my funny bone"); states this resolved without treatment.  Soreness of Rt shoulder continues, however, with certain movements or with sleeping on Rt shoulder.  States pain now localized.  Has improved with NSAIDs and Physical Therapy, but still has pain w/ lifting or reaching above shoulder-height.
Localized erythema, hyperemia 10x7 cm to the Left upper arm. No wheezes or SOB. Pulse ox 98%, T 98.3
Information has been received from the authors of the literature article. The aim of this study was to evaluate persistence of varicella (VZV) specific antibodies after vaccination with 1 or 2 doses of VZV vaccine (manufacturer unknown) and to identify determinants of varicella seropositivity in a large cohort of children and adolescents with PHIV and also in perinatally HIV-exposed but uninfected (PHEU) children. The Adolescent Master Protocol (AMP), a component of the Pediatric HIV/AIDS Cohort Study, is an ongoing prospective cohort study designed to evaluate long-term effects of HIV infection and antiretroviral therapy (ART) among children with PHIV. It enrolled 451 children with PHIV and 227 PHEU children aged 7-16 years from March 2007 to November 2009 at 15 sites. Participants were required to have complete medical history of ART use, plasma HIV RNA concentrations, and lymphocyte subset measurements since birth. There were 653 subjects (432 PHIV and 211 PHEU) whose birth years ranged from 1991 to 2002. Compared with PHEU subjects, more subjects with PHIV were living in poverty. At the time their specimens were obtained for testing, subjects with PHIV were older and had a lower BMI z score than PHEU subjects. Overall, fewer subjects with PHIV compared with PHEU subjects received the VZV vaccine, with 38% vs 18% unvaccinated, 26% vs 25% having received 1 dose, and 34% vs 55% having received 2 doses, respectively (P< .001). Subjects with PHIV were older than PHEU subjects at the time of their vaccine (median: 4.7 vs 1.5 years; P < .001), had a shorter interval between first and second vaccinations (median: 3.9 vs 6.1 years; P < .001), and had more documented HZ episodes (10% vs 0%; P < .001). The median interval from last vaccine dose to sample collection was longer for subjects with PHIV than PHEU subjects (4.2 vs 3.5 years: P< .05). Of the 653 subjects tested, 84 (24.8%) tested negative by wcELISA. Among those testing negative, 78 (11.9% of all subjects) then tested positive by gpELISA. Overall, 87% of the cohort was seropositive to varicella, with a seroprevalence among subjects with PHIV of 82% (95% CI, 78%-86%), significantly lower than among PHEU subjects (97%; 95% CI, 94%-99%). This case concerns of 4 patients who received two doses of VZV vaccine (manufacturer unknown) in the PHIV cohort, and were seronegative. This is one of several reports from the same literature source (linked to MARRS # 1602USA004824 and 1602USA004825). Additional information has been requested.
Pt reports feeling dizzy & a "rush of heat", & sweating 1 minute after vaccination. Also reports tunnel vision, but resolved w/in 2 minutes after receiving vaccine. Pt reports similar experiences w/ injuries. Pt remained on site for 30 minutes after vaccine with no worsening symptoms. Pt left the vaccine clinic LOC X4.
1-29-21 Fever, Weakness, Body & muscle pain for 2 days 2-1-21 to 2-13-21 Arm/Hand & Leg/Foot tremors & shaking 2-1-21 to 2-13-21 Body Itching, Overall Weakness, Body Tingling, Slight Numbness in Hands and Feet.
Diffuse pruritis within minutes of receiving vaccine.  Reported that she had experienced a feeling of palpitations and throat swelling 2 weeks following her first dose of vaccine.
This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 31Mar2021 at 08:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included pollen allergy on an unknown date. Concomitant medications and past drug were not reported. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination and any other medications within 2 weeks of vaccination. On 31Mar2021 at 08:15 the patient experienced blurry vision, extreme dizziness, vomiting urge (nausea) and profusely sweating (sweat dripping of the face). The patient reported that the events lasted for about 3 minutes and nothing after that. The patient was concerned and worried to take the second shot on Apr2021. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events blurry vision, extreme dizziness, vomiting urge (nausea) and profusely sweating (sweat dripping of the face) was resolved on 31Mar2021 at 08:18. No follow-up attempts are needed ; information about lot/batch number cannot be obtained.
On 3/14/02, patient had immunizations. Patient came into see doctor on 3/16/02 with complaints of left upper arm being red, swollen, hard, and painful. Patient given antibiotics.
Relates - lips tingling, fat feeling, dizziness, tunnel vision - chest tightness approx. 10 minutes post influenza vaccine. BENADRYL 50mg/PO. B/P 142/90 P 80 R-15 transported / wc to ED for observation. Prednisone in ED administered.